Current Primary Outcome Measures •Numeric Rating Scale at 60 days and 90 days post procedure (lead removal) [ Time Frame: at 60 days (plus or minus 5 days) and 90 days (plus or minus 10 days) ] ...

Nervonik, Inc., a medical technology company developing a next-generation peripheral nerve stimulation platform for chronic pain, today announced it is expanding its leadership team with the addition ...

Please provide your email address to receive an email when new articles are posted on . Patients used the device for 60 days, and effects persisted for 6 months. 71% of patients reported improved Neck ...

A research team has successfully developed a next-generation coil interface capable of efficiently and safely stimulating peripheral nerves. This breakthrough is significant in that it greatly ...

SPR announced the publication of long-term data in the journal Pain and Therapy from a cross-sectional follow-up survey of real-world patients (n=602) with chronic low back pain who had previously ...

CARLSBAD, Calif.--(BUSINESS WIRE)--One-year data from the Nalu COMFORT randomized control trial (RCT) published in the peer-reviewed Regional Anesthesia & Pain Medicine journal confirm the consistent ...

(A) Rat hindlimb motion capture for gait analysis. Four markers were attached to the hip joint, knee joint, ankle joint, and foot, respectively, to record the hindlimb’s trajectory. The hindlimb model ...

The central (CNS) and peripheral (PNS) nervous system work together to coordinate and regulate the functions of our body in addition to hosting our human intelligence. The CNS is the control center ...

LOS ANGELES, April 27, 2026 /PRNewswire/ -- Nervonik, Inc., a clinical-stage medical device company developing next-generation peripheral nerve stimulation (PNS) technologies, today announced the ...